Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Raymond完成签到,获得积分10
刚刚
默存完成签到,获得积分0
2秒前
2秒前
世上僅有的榮光之路完成签到,获得积分0
2秒前
Zoe完成签到,获得积分10
3秒前
zyueyun发布了新的文献求助30
3秒前
树袋熊发布了新的文献求助10
3秒前
科研通AI6.4应助使徒猫采纳,获得10
4秒前
调皮的笑阳完成签到 ,获得积分10
6秒前
慕青应助开心的秋采纳,获得10
6秒前
hyl-tcm完成签到,获得积分10
6秒前
LYQ完成签到 ,获得积分10
9秒前
大盘菜完成签到,获得积分10
9秒前
蛎卡奔发布了新的文献求助10
9秒前
yh完成签到,获得积分10
9秒前
ming830完成签到,获得积分10
10秒前
Nyuki完成签到,获得积分10
11秒前
番茄黄瓜芝士片完成签到 ,获得积分10
11秒前
zt完成签到,获得积分10
12秒前
闫永娟完成签到 ,获得积分10
12秒前
13秒前
胡江完成签到 ,获得积分10
14秒前
袁玥完成签到,获得积分10
14秒前
自信向梦完成签到,获得积分10
15秒前
15秒前
zyy完成签到,获得积分10
15秒前
张欢馨应助过时的亦寒采纳,获得10
15秒前
DoctorSUN完成签到,获得积分10
17秒前
蝌蚪完成签到,获得积分10
17秒前
宗剑完成签到,获得积分10
17秒前
小陶子完成签到,获得积分10
18秒前
Ada完成签到 ,获得积分10
18秒前
悦耳冰蓝完成签到,获得积分10
18秒前
宁阿霜完成签到,获得积分10
19秒前
文章多多发布了新的文献求助10
19秒前
20秒前
22秒前
拙青完成签到,获得积分10
22秒前
安琪完成签到,获得积分10
22秒前
烟花应助一个酸葡萄干采纳,获得10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing 36th edition 400
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6362286
求助须知:如何正确求助?哪些是违规求助? 8176007
关于积分的说明 17224813
捐赠科研通 5416998
什么是DOI,文献DOI怎么找? 2866674
邀请新用户注册赠送积分活动 1843775
关于科研通互助平台的介绍 1691614